[New pathogenetic aspects of ankylosing spondylitis].
Ankylosing spondylitis is one of the oldest diseases in humans; however, it is still one of the most fascinating and mysterious in human pathology. The unusual combination of both fundamental pathological processes: inflammation and ossification (which are mostly independent in respect to time and place) is unique. Until 1973, ankylosing spondylitis did not attract much immunological research. After the detection of an association between HLA B27 and the disease, clinical and immunological research was stimulated. It was supposed that HLA B27 may be a pathogenic factor. Meanwhile, it has become well known that HLA B27 itself is not required for development of the disease; however, discovery of immunological cross-reactivity between HLA B27 and some Klebsiella antigens inspired pathogenic considerations. It is discussed that the structural similarities between enteric bacteria and HLA B27 induce autoantibodies, or that HLA B27 plays a role in antigen recognition. Possibly, HLA B27 may also act as a receptor for infectious agents and their products. Fascinating, but controversely discussed is the hypothesis that bacterial products modify the B27 molecule and, in this way, trigger the disease. All present theories about pathogenesis of ankylosing spondylitis are unsatisfactory, because many important questions cannot be answered. There are no explanations for the unusual affinity of possible pathogenic immune reactions to the spine and other organs, the induction of ossification, the merging of cartilage, or the development of sacroilitis. Especially, we do not know the important bridge (if one exists) between inflammation and ossification. The typical ossification of the spine is of dramatic consequence for the patient in respect to function and mobility.(ABSTRACT TRUNCATED AT 250 WORDS)
Schmidt
K L
KL
Klinikum der Justus-Liebig-Universität Giessen, Bad Nauheim.
D001323:Autoantibodies / Q000032:analysis; D003429:Cross Reactions / Q000276:immunology; D015796:HLA-B27 Antigen / Q000032:analysis / Q000235:genetics; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007422:Intestines / Q000382:microbiology; D007709:Klebsiella / Q000276:immunology; D012307:Risk Factors; D013167:Spondylitis, Ankylosing / Q000175:diagnosis / Q000235:genetics / Q000276:immunology*
D001323:Autoantibodies; D015796:HLA-B27 Antigen; D007070:Immunoglobulin A
Neue pathogenetische Aspekte der ankylosierenden Spondylitis.